View All Documents & Correspondence
Imidazopyridine Compound
Abstract: [Problem] To provide an excellent therapeutic or prophylactic agent for cardiovascular diseases on the basis of cGMP production increasing activity attributed to soluble guanylate cyclase activating activity. [Solution] It was discovered that an imidazopyridine compound having a carbamoyl group at the 3 position of an imidazo[1 2 a]pyridine skeleton and having a substituent attached to the 8 position of the skeleton through an oxygen atom exhibits cGMP production increasing activity attributed to potent soluble guanylate cyclase activating activity and can be used in an excellent therapeutic or prophylactic agent for various cardiovascular diseases associated with soluble guanylate cyclase and the invention was completed.
Notices, Deadlines & Correspondence
Patent Information
Applicants
Astellas Pharma Inc.
Inventors
1. KOGA Yuji
2. MAENO Kyoichi
3. SATO Ippei
4. IMAMURA Yoshimasa
5. HANAZAWA Takeshi
6. IIDA Maiko
7. OHNE Kazuhiko
8. IMAMURA Kenichiro
9. WATANABE Tsubasa
10. NOZAWA Eisuke
11. SHIBATA Hiroshi
Specification
PLS SEE ATTACHEMENTS.
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 9465-CHENP-2013 FORM-3 14-07-2014.pdf | 2014-07-14 |
| 1 | 9465-CHENP-2013 POWER OF ATTORNEY 26-11-2013.pdf | 2013-11-26 |
| 2 | 9465-CHENP-2013.pdf | 2014-01-10 |
| 2 | 9465-CHENP-2013 PCT 26-11-2013.pdf | 2013-11-26 |
| 3 | 9465-CHENP-2013 FORM-5 26-11-2013.pdf | 2013-11-26 |
| 3 | 9465-CHENP-2013 ABSTRACT 26-11-2013.pdf | 2013-11-26 |
| 4 | 9465-CHENP-2013 CLAIMS 26-11-2013.pdf | 2013-11-26 |
| 4 | 9465-CHENP-2013 FORM-3 26-11-2013.pdf | 2013-11-26 |
| 5 | 9465-CHENP-2013 FORM-2 26-11-2013.pdf | 2013-11-26 |
| 5 | 9465-CHENP-2013 CORRESPONDENCE OTHERS 26-11-2013.pdf | 2013-11-26 |
| 6 | 9465-CHENP-2013 FORM-1 26-11-2013.pdf | 2013-11-26 |
| 6 | 9465-CHENP-2013 DESCRIPTION (COMPLETE) 26-11-2013.pdf | 2013-11-26 |
| 7 | 9465-CHENP-2013 ENGLISH TRANSLATION 26-11-2013.pdf | 2013-11-26 |
| 7 | 9465-CHENP-2013 DESCRIPTION (COMPLETE)1 26-11-2013.pdf | 2013-11-26 |
| 8 | 9465-CHENP-2013 ENGLISH TRANSLATION 26-11-2013.pdf | 2013-11-26 |
| 8 | 9465-CHENP-2013 DESCRIPTION (COMPLETE)1 26-11-2013.pdf | 2013-11-26 |
| 9 | 9465-CHENP-2013 FORM-1 26-11-2013.pdf | 2013-11-26 |
| 9 | 9465-CHENP-2013 DESCRIPTION (COMPLETE) 26-11-2013.pdf | 2013-11-26 |
| 10 | 9465-CHENP-2013 CORRESPONDENCE OTHERS 26-11-2013.pdf | 2013-11-26 |
| 10 | 9465-CHENP-2013 FORM-2 26-11-2013.pdf | 2013-11-26 |
| 11 | 9465-CHENP-2013 CLAIMS 26-11-2013.pdf | 2013-11-26 |
| 11 | 9465-CHENP-2013 FORM-3 26-11-2013.pdf | 2013-11-26 |
| 12 | 9465-CHENP-2013 FORM-5 26-11-2013.pdf | 2013-11-26 |
| 12 | 9465-CHENP-2013 ABSTRACT 26-11-2013.pdf | 2013-11-26 |
| 13 | 9465-CHENP-2013.pdf | 2014-01-10 |
| 13 | 9465-CHENP-2013 PCT 26-11-2013.pdf | 2013-11-26 |
| 14 | 9465-CHENP-2013 POWER OF ATTORNEY 26-11-2013.pdf | 2013-11-26 |
| 14 | 9465-CHENP-2013 FORM-3 14-07-2014.pdf | 2014-07-14 |